Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1994-05-31
1999-02-16
Smith, Lynette F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
530350, 4241881, 4241841, 4242041, A61K 3921, A61K 3900, A61K 3938, C07K 100
Patent
active
058717463
ABSTRACT:
Cytotoxic lymphocyte-inducing lipopeptides comprising a peptide part having between 10 and 40 amino acids approximately and comprising at least one antigenic determinant. The lipopeptides also comprise one or more chains derived from fatty acids and one or more modified steroid groups.
Said lipopeptides may be used for immunizing the human or animal body against pathogenic agents such as viruses or parasites. The peptide part may, in particular, be a fragment of the protein encoded by the ENV gene, by the NEF gene or by the GAG gene of HIV viruses. DA.
REFERENCES:
Martinon, et al, 1992, "Immunization of mice with lipopeptides . . . " J. munol. 145 (10):3416-22.
Bahraoui, et al, 1992, "Immunogenicity of the human . . . " AIDS Res Hum. Retro. 6(9): 1087-1098.
Haynes, 1993, "Scientific and Social Issues . . . " Science 260: 1279-1286.
Butini, et al, 1994, "Comparative analysis of HIV-Specific . . . " J. Cell. Biochem. Suppl. 18B, Abstract J306.
Fox, 1994, "No Winners Against AIDS", Biotechnology 12;128.
Boutillon Christophe
Gomard Elisabeth
Gras-Masse Helene
Levy Jean-Paul
Magne Remy
Institut National de la Sainte et de la Recherche Medicale (INSE
Institut Pasteur
Institut Pasteur de Lille
Smith Lynette F.
LandOfFree
Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2059719